Reason for request
Inclusion on the list of medicines reimbursed by National Insurance and approved for use by hospitals.
Clinical Benefit
| Insufficient |
The actual benefit of LERCAPRESS 10 mg/10 mg is insufficient in view of the available clinical data: this data is insufficient to assess its value for the management of hypertensive patients. |
| Substantial |
|
Clinical Added Value
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
WVm4cUNG9PQr9Zwy
